AQP4 and neuromyelitis optica: The anti-AQP4 antibodies derived from the serum of patients and human complement were used for generating a NMO rodent model that was based on the anti-AQP4-mediated astrocyte damage in Lewis rats, which are prone to develop spontaneous autoimmune neuroinflammatory diseases.